ADMA Biologics
ADMA
ADMA
23 hedge funds and large institutions have $54.7M invested in ADMA Biologics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
21% more funds holding
Funds holding: 19 → 23 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
23
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.95M | |
| 2 | +$6.72M | |
| 3 | +$3.54M | |
| 4 |
6CM
683 Capital Management
New York
|
+$3.05M |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
+$1.6M |
Top Sellers
| 1 | -$302K | |
| 2 | -$66K | |
| 3 | -$63K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$36K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10K |